
A new-user cohort study found that achieving a serum urate level below 6 mg/dL within 12 months was associated with a 9% relative reduction in MACE over 5 years.

Professor, Professor of Rheumatology at the University of Nottingham, United Kingdom

A new-user cohort study found that achieving a serum urate level below 6 mg/dL within 12 months was associated with a 9% relative reduction in MACE over 5 years.